全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Safety and Yield of Diagnostic ERCP in Liver Transplant Patients with Abnormal Liver Function Tests

DOI: 10.1155/2014/314927

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background. Abnormal liver enzymes postorthotopic liver transplant (OLT) may indicate significant biliary pathology or organ rejection. There is very little known in the literature regarding the current role of diagnostic ERCP in this scenario. Aim. To review the utility of diagnostic ERCP in patients presenting with abnormal liver function tests in the setting of OLT. Methods. A retrospective review of diagnostic ERCPs in patients with OLT from 2002 to 2013 from a prospectively maintained, IRB approved database. Results. Of the 474 ERCPs performed in OLT patients, 210 (44.3%; 95% CI 39.8–48.8) were performed for abnormal liver function tests during the study period. Majority of patients were Caucasian (83.8%), male (62.4%) with median age of 55 years (IQR 48–62 years). Biliary cannulation was successful in 99.6% of cases and findings included stricture in 45 (21.4 %); biliary stones/sludge in 23 (11%); biliary dilation alone in 31 (14.8%); and normal in 91 (43.3%). Three (1.4%) patients developed mild, self-limiting pancreatitis; one patient (0.5%) developed cholangitis and two (1%) had postsphincterotomy bleeding. Multivariate analyses showed significant association between dilated ducts on imaging with a therapeutic outcome. Conclusion. Diagnostic ERCP in OLT patients presenting with liver function test abnormalities is safe and frequently therapeutic. 1. Introduction Complications after orthotopic liver transplantation (OLT) include allograft rejection, infections due to immunosuppression, disease recurrence, and biliary tract pathology. Amongst these, biliary tract disease remains the most common, identified in up to 40% of cases [1–3]. The majority of these biliary disorders respond well to endoscopic management and prompt therapy avoids graft dysfunction and results in good outcomes [4]. Furthermore, self-expanding metal stent insertion for treatment of biliary complications after liver transplant is an alternative to surgery [5, 6]. However, diagnosing biliary complications after liver transplant is challenging as presentation can be atypical with nonspecific symptoms while laboratory and imaging testing are poorly sensitive [7, 8]. The algorithm employed to investigate includes transabdominal ultrasound scan with Doppler studies followed by MRCP and endoscopic or percutaneous cholangiography for therapy depending on the anatomy. Although ERCP with dynamic cholangiography is considered the gold standard for investigating the biliary tree, the procedure is invasive and has now transitioned primarily into a therapeutic endeavor due to evolution of

References

[1]  R. Rerknimitr, S. Sherman, E. L. Fogel et al., “Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy,” Gastrointestinal Endoscopy, vol. 55, no. 2, pp. 224–231, 2002.
[2]  D. Seehofer, D. Eurich, W. Veltzke-Schlieker, and P. Neuhaus, “Biliary complications after liver transplantation: old problems and new challenges,” American Journal of Transplantation, vol. 13, no. 2, pp. 253–265, 2013.
[3]  A. Pascher and P. Neuhaus, “Biliary complications after deceased-donor orthotopic liver transplantation,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 13, no. 6, pp. 487–496, 2006.
[4]  P. J. Thuluvath, P. R. Pfau, M. B. Kimmey, and G. G. Ginsberg, “Biliary complications after liver transplantation: the role of endoscopy,” Endoscopy, vol. 37, no. 9, pp. 857–863, 2005.
[5]  M. Di Pisa, M. Traina, R. Miraglia et al., “Use of a self-expandable metallic stent for large bile leakage following orthotopic liver transplant,” Endoscopy, vol. 41, supplement 2, pp. E4–E5, 2009.
[6]  M. Traina, I. Tarantino, L. Barresi et al., “Efficacy and safety of fully covered self-expandable metallic stents in biliary complications after liver transplantation: a preliminary study,” Liver Transplantation, vol. 15, no. 11, pp. 1493–1498, 2009.
[7]  D. E. Eckhoff, T. H. Baron, W. G. Blackard et al., “Role of ERCP in asymptomatic orthotopic liver transplant patients with abnormal liver enzymes,” The American Journal of Gastroenterology, vol. 95, no. 1, pp. 141–144, 2000.
[8]  Y. M. Shastri, N. M. Hoepffner, B. Akoglu et al., “Liver biochemistry profile, significance and endoscopic management of biliary tract complications post orthotopic liver transplantation,” World Journal of Gastroenterology, vol. 13, no. 20, pp. 2819–2825, 2007.
[9]  J. E. Jorgensen, A. K. Waljee, M. L. Volk et al., “Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis,” Gastrointestinal Endoscopy, vol. 73, no. 5, pp. 955–962, 2011.
[10]  C. Sanna, C. Giordanino, I. Giono et al., “Safety and efficacy of endoscopic retrograde cholangiopancreatography in patients with post-liver transplant biliary complications: results of a cohort study with long-term follow-up,” Gut and Liver, vol. 5, no. 3, pp. 328–334, 2011.
[11]  B. J. Elmunzer, A. T. Debenedet, M. L. Volk et al., “Clinical yield of diagnostic endoscopic retrograde cholangiopancreatography in orthotopic liver transplant recipients with suspected biliary complications,” Liver Transplantation, vol. 18, no. 12, pp. 1479–1484, 2012.
[12]  P. B. Cotton, G. Lehman, J. Vennes et al., “Endoscopic sphincterotomy complications and their management: an attempt at consensus,” Gastrointestinal Endoscopy, vol. 37, no. 3, pp. 383–393, 1991.
[13]  D. Balderramo, J. M. Bordas, O. Sendino et al., “Complications after ERCP in liver transplant recipients,” Gastrointestinal Endoscopy, vol. 74, no. 2, pp. 285–294, 2011.
[14]  P. J. Thuluvath, T. Atassi, and J. Lee, “An endoscopic approach to biliary complications following orthotopic liver transplantation,” Liver International, vol. 23, no. 3, pp. 156–162, 2003.
[15]  J. M. Scheiman, R. C. Carlos, J. L. Barnett et al., “Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis,” The American Journal of Gastroenterology, vol. 96, no. 10, pp. 2900–2904, 2001.
[16]  J. W. Poley, M. N. Lekkerkerker, H. J. Metselaar, E. J. Kuipers, and M. J. Bruno, “Clinical outcome of progressive stenting in patients with anastomotic strictures after orthotopic liver transplantation,” Endoscopy, vol. 45, no. 7, pp. 567–570, 2013.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133